Cost-consequence analysis of using neurofarmagen in the decision making process during the treatment of patients with depression in the U.S.
| dc.contributor.author | Espadaler, P. | |
| dc.contributor.author | Carcedo, D. | |
| dc.contributor.author | Pérez Mitre, A. | |
| dc.contributor.author | Menchón, José M. | |
| dc.contributor.author | Saiz Ruiz, J. | |
| dc.contributor.author | Bobes, Julio | |
| dc.contributor.author | Vieta Pascual, Eduard | |
| dc.contributor.author | Álvarez, Enric | |
| dc.contributor.author | Pérez, V | |
| dc.date.accessioned | 2018-02-28T10:40:57Z | |
| dc.date.available | 2018-02-28T10:40:57Z | |
| dc.date.issued | 2017 | |
| dc.identifier.issn | 1098-3015 | |
| dc.identifier.issn | 1524-4733 | |
| dc.identifier.uri | http://hdl.handle.net/10651/46093 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Value In Health, 20 | |
| dc.rights | ©, | |
| dc.source | WOS:000413599902429 | |
| dc.title | Cost-consequence analysis of using neurofarmagen in the decision making process during the treatment of patients with depression in the U.S. | |
| dc.type | conference output | spa |
| dc.identifier.doi | 10.1016/j.jval.2017.08.1891 | |
| dc.relation.publisherversion | https://doi.org/10.1016/j.jval.2017.08.1891 |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||